surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 SURMOUNT-2: confers about 15% in adults with obesity and Tirzepatide Shows Superior Weight Loss

Patients without commercial insurance can use the Eli Lilly savings card to save up to $463-$647 per fill, potentially bringing costs down significantly

The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment)

How to Manage Tirzepatide Dizziness Effectively Tirzepatide, a dual GIP and GLP-1 receptor agonist, has become a popular treatment for type 2 diabetes and weight loss

This approach helps reduce digestive side effects while improving appetite control and metabolic balance

In many cases, injections are administered into the fatty tissue of the abdomen, thigh, or upper arm, as directed